| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Istituto di Tecnologie Biomediche, Consiglio Nazionale delle Ricerche, Via Fratelli Cervi, 93, 20090 Segrate, Milan, Italy [A. M., D. Z., A. V., P. V.]; Genetics Branch, Center for Cancer Research, National Cancer Institute/NIH, Bethesda, Maryland 20892-0913 [C. M., T. R.]; Centro Ricerche Parco Scientifico "E. Menni," Ospedale Poliambulanza, 25100 Brescia, Italy [D. Z.]; Istituto Zooprofilattico Sperimentale delle Regioni Lazio e Toscana, Dipartimento di Firenze, 50010 Florence, Italy [E. I.]; Dipartimento di Oncologia Biologia e Genetica, Università di Genova, I.S.T., 16132 Genoa, Italy [O. B.]; and Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche, 56124 Pisa, Italy [L. C.]
The relative contribution of aneuploidy and gene mutations to human tumorigenesis is not yet known. Studies in mice have demonstrated that even single point mutations in oncogenes and tumor suppressor genes can dramatically increase tumor frequency. However, models to evaluate the definitive role of aneuploidy and genomic instability are not yet available. Human fibroblast cells have long been used as a tool for investigating proliferation, senescence, immortalization, and tumorigenesis, all processes that are strongly interrelated. We have now used antisense and ribozyme-mediated temporary inhibition of BUB1 to study the consequences of mitotic checkpoint failure on the development of aneuploidy. The analysis of cell colonies selected by soft agar growth showed evidence of chromosome instability and delayed senescence, without being tumorigenic in nude mice. Our data suggest that chromosomal instability and aneuploidy are early changes that precede tumorigenicity in the multistep process leading to neoplastic transformation.
This article has been cited by other articles:
![]() |
P. Morciano, C. Carrisi, L. Capobianco, L. Mannini, G. Burgio, G. Cestra, G. E. De Benedetto, D. F.V. Corona, A. Musio, and G. Cenci A conserved role for the mitochondrial citrate transporter Sea/SLC25A1 in the maintenance of chromosome integrity Hum. Mol. Genet., November 1, 2009; 18(21): 4180 - 4188. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Burum-Auensen, P M DeAngelis, A R Schjolberg, J. Roislien, S N Andersen, and O P F Clausen Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis J. Clin. Pathol., December 1, 2007; 60(12): 1403 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Perez de Castro, G. de Carcer, and M. Malumbres A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy Carcinogenesis, May 1, 2007; 28(5): 899 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Musio, C. Montagna, T. Mariani, M. Tilenni, M. L. Focarelli, L. Brait, E. Indino, P. A. Benedetti, L. Chessa, A. Albertini, et al. SMC1 involvement in fragile site expression Hum. Mol. Genet., February 15, 2005; 14(4): 525 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.C. Reshmi and S.M. Gollin Chromosomal Instability in Oral Cancer Cells Journal of Dental Research, February 1, 2005; 84(2): 107 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Myung, S. Smith, and R. D. Kolodner Mitotic checkpoint function in the formation of gross chromosomal rearrangements in Saccharomyces cerevisiae PNAS, November 9, 2004; 101(45): 15980 - 15985. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Deocaris, S. C. Kaul, K. Taira, and R. Wadhwa Emerging Technologies: Trendy RNA Tools for Aging Research J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2004; 59(8): B771 - B783. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Lee, M. K. Keutmann, M. L. Dowling, E. Harris, G. Chan, and G. D. Kao Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells Mol. Cancer Ther., June 1, 2004; 3(6): 661 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hu, T. Wang, G. D. Stormo, and J. I. Gordon RNA interference of achaete-scute homolog 1 in mouse prostate neuroendocrine cells reveals its gene targets and DNA binding sites PNAS, April 13, 2004; 101(15): 5559 - 5564. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cotsiki, R. L. Lock, Y. Cheng, G. L. Williams, J. Zhao, D. Perera, R. Freire, A. Entwistle, E. A. Golemis, T. M. Roberts, et al. Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1 PNAS, January 27, 2004; 101(4): 947 - 952. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |